|
Complication risk not related to timing between rituximab, surgery for RA patients
Healio Jérémie Sellam, MD, PhD, of the department of rheumatology, University of Paris VI, and colleagues studied 133 patients with rheumatoid arthritis (RA; median age, 59 years) who underwent 140 procedures within 1 year of rituximab (RTX) infusion and had … |
Picture desk live: the best news photographs of the day – The Guardian
Picture desk live: the best news photographs of the dayThe GuardianSoldiers stop survivors from going near an army helicopter as its lands during rescue operations at Badrinath, India. Early monsoon rains have swollen the Ganges, and swept away houses,…
NIST, Stanford Launch Biomedical Measurement Science Program; Partners … – GenomeWeb
NIST, Stanford Launch Biomedical Measurement Science Program; Partners …GenomeWebThe ABMS partners plan to focus on technology areas that are edging their way into clinical medicine and other applications, including the use of high-throughput sequenc…
Novartis heart failure drug gets FDA incentives – Yahoo! New Zealand News
Economic Times |
Novartis heart failure drug gets FDA incentives
Yahoo! New Zealand News NEW YORK (AP) — Novartis AG said Friday its drug serelaxin, a treatment for acute heart failure, received breakthrough therapy status from the Food and Drug Administration. The drug is intended to treat symptoms of acute heart failure episodes … US FDA deems Novartis’ heart failure candidate a ‘breakthrough’PMLiVE FDA grants Breakthrough Therapy designation to Novartis’ serelaxin (RLX030 …FierceBiotech Novartis Heart-Failure Drug Wins ‘Breakthrough’ Status at FDABusinessweek TheHeart.Org –DailyFinance all 13 news articles » |
UAB Hospital Emergency Department to screen patients for hepatitis C – UAB News
UAB Hospital Emergency Department to screen patients for hepatitis CUAB NewsBefore 1992, when widespread screening of the blood supply began in the United States, hepatitis C also was commonly spread through blood transfusions and organ transplants. Th…
FDA grants Breakthrough Therapy designation to Novartis' serelaxin (RLX030 … – FierceBiotech
Economic Times |
FDA grants Breakthrough Therapy designation to Novartis’ serelaxin (RLX030 …
FierceBiotech Basel, June 21, 2013 – Novartis announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation status to RLX030 (serelaxin), an investigational treatment for patients with acute heart failure (AHF). The FDA … Novartis heart failure drug gets FDA incentivesBusinessweek US FDA deems Novartis’ heart failure candidate a ‘breakthrough’PMLiVE Serelaxin, Experimental Heart Drug From Norvartis, Obtains FDA Breakthrough …Medical Daily Fox News –Bloomberg all 9 news articles » |
Fifty things we love about travel right now – The Age
The Age |
Fifty things we love about travel right now
The Age Whether it’s the food stalls of Kowloon’s Temple Street night market or the scallop and prawn dumplings at the three-star Lung King Heen, Hong Kong’s dynamic, eclectic food scene takes your taste buds for a walk on the wild side. … Try Nappa Dori for … |
Moving Image: Our Week In Photos (June 15-21) – Huffington Post
Moving Image: Our Week In Photos (June 15-21)Huffington Post… on June 15,2013 in Johannesburg, South Africa. The former South African President and leader of the anti-apartheid movement is spending a seventh night in hospital and is reported to be re…
Organ Transplantation In Children: What Is Ethical? – Mondaq News Alerts (registration)
CBS NewsOrgan Transplantation In Children: What Is Ethical?Mondaq News Alerts (registration)New ethical questions have been spurred by the recent lung transplantation case involving a 10-year old girl from Pennsylvania. Sarah Murnaghan, who was diagnos…
We Seek Not To Become Machines, But To Keep Up With Them – Institute for Ethics and Emerging Technologies
We Seek Not To Become Machines, But To Keep Up With ThemInstitute for Ethics and Emerging TechnologiesWe could expect this to be equivalent to temporary brain death or to destructive uploading without any sort of gradual replacement, integration or tra…